{"meshTagsMajor":["Neoadjuvant Therapy"],"meshTags":["Antineoplastic Combined Chemotherapy Protocols","Carcinoma, Non-Small-Cell Lung","Humans","Lung Neoplasms","Neoadjuvant Therapy"],"meshMinor":["Antineoplastic Combined Chemotherapy Protocols","Carcinoma, Non-Small-Cell Lung","Humans","Lung Neoplasms"],"organisms":["9606"],"publicationTypes":["Journal Article","Review"],"abstract":"Induction chemotherapy has been proven to improve survival in patients with Stage IIIA non-small cell lung cancer, and is under investigation for early stage disease. Controversy still exists regarding the choice of chemotherapy regimens, patient selection, and inclusion of radiation therapy.","title":"Controversial issues regarding the use of induction chemotherapy for lung cancer.","pubmedId":"16253821"}